How much does compounded semaglutide cost per month compared to Wegovy?

You're asking a great and very common question! The cost difference between name-brand Wegovy and compounded semaglutide is significant, but it comes with important distinctions regarding regulation and insurance coverage.

Here's a breakdown:

Wegovy (Name-Brand Semaglutide)

• Average Cash Price (without insurance): Expect to pay anywhere from $1,300 to $1,600 per month. This is the list price set by the manufacturer, Novo Nordisk.
• With Insurance: This is where it gets highly variable.
  • Coverage Depends on Your Plan: Many insurance plans do not cover weight loss medications, or they require strict prior authorization, proof of failed attempts with other methods, and a high BMI.
  • Deductibles and Co-pays: Even if covered, you'll likely be responsible for your deductible (which can be thousands of dollars) before your insurance starts paying a significant portion. After that, you'll have co-pays or co-insurance, which can still be hundreds of dollars per month.
  • Manufacturer Savings Programs: Novo Nordisk often offers savings cards that can reduce the out-of-pocket cost for eligible commercially insured patients by several hundred dollars per month (e.g., bringing it down to $25-$500 per month, depending on your plan and the specific offer).

Compounded Semaglutide

• Average Cost (out-of-pocket): Compounded semaglutide typically costs much less, ranging from $200 to $600 per month. This price usually includes the medication itself, often mixed with B12, and sometimes consultation fees from telehealth providers.
• Insurance Coverage: Never covered by insurance. Compounded medications are not FDA-approved finished drug products, and insurance companies will not reimburse for them. You will pay for this entirely out-of-pocket.
• Source and Contents: Compounded semaglutide is made by compounding pharmacies using bulk drug substances, often combined with other ingredients like B12. It is not the exact formulation or strength of the FDA-approved Wegovy (or Ozempic).
• Regulatory Status: This is a crucial difference. While the active ingredient semaglutide is FDA-approved, the compounded product itself is not FDA-approved for safety, purity, or effectiveness for weight loss. The FDA has issued warnings about the risks associated with compounded semaglutide, particularly concerning products made with semaglutide salts (like semaglutide sodium or acetate) which have not been shown to be safe and effective.

Key Takeaways:

• Cost: Compounded semaglutide is significantly cheaper upfront ($200-$600/month) than Wegovy's cash price ($1,300-$1,600/month).
• Insurance: Wegovy may be covered by insurance (check your specific plan!), but compounded semaglutide never is.
• FDA Approval: Wegovy is an FDA-approved drug from Novo Nordisk for weight loss. Compounded semaglutide is not an FDA-approved finished drug product, which means there's less oversight on its quality, purity, and potency.
• Availability: Due to shortages of Wegovy, compounded versions have become more prevalent, but come with the aforementioned regulatory and safety concerns.

Always consult with a healthcare professional to discuss which option is appropriate and safe for your individual health needs.